What this measures

The countdown tracks progress toward a single milestone: longevity escape velocity. It is not a countdown to a cure for aging, and it is not a prediction that anyone alive today will become immortal. It is one conservative, provisional estimate of how far current science is from that milestone, built from publicly tracked signals across a set of longevity-relevant research fields.

Longevity escape velocity (LEV) is commonly used in the longevity research community to describe a hypothetical point at which medical progress extends healthy human lifespan faster than time passes — effectively causing remaining life expectancy to stop shrinking with age. Reaching LEV would not mean aging is cured or that death becomes impossible; it would mean the rate of progress has, for a time, outrun the rate of biological decline.

The figure shown on the dashboard is the base case. Two other scenarios bound the range of outcomes:

The estimate draws on a provisional field taxonomy of eight longevity-relevant research fields. Four are currently tracked with provisional scores; the other four are published as a provisional field taxonomy only — named and scoped, but not yet scored. No score has been invented for them.

• Rejuvenation & Regeneration
• Biomarkers & Diagnostics
• Geroscience Drugs & Trials
• Gene Therapy & Delivery
• AI Drug Discovery — Score pending
• Organ Replacement & Biofabrication — Score pending
• Immune Engineering & Cancer Control — Score pending
• Enabling Technology & Automation — Score pending

See current field scores →

The estimate is provisional and will move as the underlying field scores are revised. It shifts later if trials, funding, or research output slow down, and earlier if progress compounds faster than expected across the tracked fields — or if a regulatory pathway for aging opens sooner than the last twenty years suggest. It is not a fixed target, and every revision is recorded in the version history of the parameter file.

There is now a published calculation model, and its code, parameters and fixed random seed are all in the repository, so the figure is reproducible by anyone. That is a much weaker claim than it sounds: no peer review and no third-party audit back it, the field readiness scores are informed judgements rather than measurements, and the eight-field taxonomy is this site’s own rather than a recognised scientific classification. Forecasting the pace of biomedical progress is inherently uncertain. Read this as a transparent, arguable estimate — not a validated scientific result.